NeoGenomics
Fort Myers · Founded 1998
About NeoGenomics
NeoGenomics is a cancer reference laboratory that provides cancer testing and partnership programs to pathologists and oncologists. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations throughout the United States, and pharmaceutical firms in Europe and Asia.
Company Facts
- Founded: 1998
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $500K – $1M
- Total funding: $925.9M
- Funding stage: IPO
- Last round: Post-IPO Equity (May 2021)
- Ticker: nasdaq:NEO
- Website: neogenomics.com
- Phone: (239) 768-0600
Industries & Categories
Biotechnology, Genetics, Health Care, Health Diagnostics, Medical
Social Profiles
Canonical: https://fsome.com/organization/neogenomics-90316 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.